PINK:GLUC

Glucose Health Stock News

etoro logo Buy GLUC
*Your capital is at risk
$0.368
+0.0027 (+0.741%)
At Close: Jun 03, 2026
BENTONVILLE, Ark., April 01, 2024 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) is pleased to announce the expansion of its innovative Fiber Up® brand of soluble fiber supplements, just launch
BENTONVILLE, Ark., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Glucose Health, Inc., the pioneer in delicious manufacturing prebiotic soluble fiber enriched nutrition beverages, proudly confirms the granting of
• Consumers Trust Delicious & Nutritious GLUCODOWN® For Maintenance of Healthy Blood Sugar • • Consumers Trust Delicious & Nutritious GLUCODOWN® For Maintenance of Healthy Blood Sugar •
BENTONVILLE, Ark., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTCPK: GLUC), manufacturer of GLUCODOWN®, the innovative brand of delicious and nutritious iced teas and drink mixes, uniqu

Glucose Health, Inc. Fiscal 2022 Annual Report

07:23pm, Thursday, 23'rd Mar 2023 InvestorsHub
    Glucose Health, Inc. Fiscal 2022 Annual Report BENTONVILLE Arkansas -- March 23, 2023 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial metrics presented in its Annual Report posted today at OTCMarkets.com. For fiscal 2022, Glucose Health, Inc. surpassed $1m in annual revenues for the first time in its history.  Additionally, despite intense ingredient, packaging and...
We discovered Glucose Health, Inc. back in April of 2017 when the shares were fetching between $0.07 and $0.10. In January of 2021, GLUC shares reached a high of almost $9.00 after reporting strong sa
    IMPORTANT CORPORATE DEVELOPMENTS - GLUCOSE HEALTH, INC. (OTC: GLUC) Bentonville, AR -- November 3, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: GLUC) ("Company") confirms the following important corporate developments.   Three outstanding candidates have now accepted nominations to serve as independent directors of the Company. Charters for the enactment of Audit, Compensation and Corporate Governance/Nominations committees, eac...
    Glucose Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal 2022 BENTONVILLE AR -- October 24, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial information from its third Quarterly Report of Fiscal 2022, for the period ended September 30, 2022, posted today at OTCMarkets.com. Q3 2022 Revenue of $340,681 vs. $234,930 for Q3 2021 = a 45% increase. Q3 2022 Gross Prof...
Glucose Health, Inc. is a micro-cap company that is on the leading edge of a long-term global macro trend that likely has a decades-long runway in front of it. This macro trend, which offers a unique

Glucose Health, Inc. Corporate Update

11:35am, Thursday, 24'th Mar 2022 InvestorsHub
   Glucose Health, Inc. Corporate Update BENTONVILLE, AR -- March 24, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: GLUC) ("Company") today provided the following corporate update, in response to requests from shareholders and interested parties for clarification of recent corporate events.   John Fieldly, the current Chief Executive Officer of Celsius Holdings, Inc. (Celsius), Hal Kravitz, a current member of the Board of Directors of...

Glucose Health, Inc. Corporate Update

07:00pm, Thursday, 17'th Mar 2022 InvestorsHub
  Glucose Health, Inc. Corporate Update BENTONVILLE, AR -- March 17, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. ("Company") announced today, it has accepted the resignations of Hal Kravitz and John Fieldly from the Company's board of directors.      About Glucose Health, Inc.   Manufactured by Glucose Health, Inc., the GLUCODOWN® brand is defining a new beverage industry category – functional, diabetic friendly, bevera...

Glucose Health, Inc. Fiscal 2021 Annual Report

01:00pm, Thursday, 10'th Feb 2022 InvestorsHub
  Glucose Health, Inc. Fiscal 2021 Annual Report BENTONVILLE, AR -- February 10, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial metrics presented in its Fiscal 2021 Annual Report posted today at OTCMarkets.com. In fiscal 2021, Glucose Health, Inc. more than doubled gross profits, effectively doubled revenue, and achieved the unique status of a debt free, emerging growth, company. Fis...
    Glucose Health, Inc. USPTO Patent Filing Asserts First Use of Nutritional Composition Underlying GLUCODOWN® BENTONVILLE, AR -- December 28, 2021 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: "GLUC") ("Company") is pleased to advise that a patent application for "Compositions and Methods for Metabolic Health" was filed with the United States Trademark and Patent Office (USPTO) on December 23, 2021, on behalf of the Company....
BENTONVILLE, Ark., Sept. 7, 2021 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to announce today, after 16 months of product development, new GLUCODOWN® "enhanced water" dr
BENTONVILLE, AR, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC Pink: GLUC) (“Company”) is pleased to announce today, after 16 months of product development, new GLUCODOWN® "enhance
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE